Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Jiancong Xie

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5020720153. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 2 papers · 2024: none · 2025: 1 paper

Papers 3

  1. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Co-author DOI 10.1016/j.canlet.2025.217726↗
  2. Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1178966↗
  3. The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling. Co-author DOI 10.3390/cancers15225454↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tuo Hu · 2 shared papers, 2023–2025 · strength 0.36
  2. Weidong Pan · 2 shared papers, 2023–2025 · strength 0.36
  3. Jing Chen · 2 shared papers, 2023–2025 · strength 0.36
  4. Hao Zhang · 2 shared papers, 2023 · strength 0.34
  5. Tao Ma · 1 shared paper, 2025 · strength 0.19
  6. Hao Zhang · 1 shared paper, 2025 · strength 0.19
  7. Wenguang Peng · 1 shared paper, 2023 · strength 0.18
  8. Weidong Pan · 1 shared paper, 2023 · strength 0.18
  9. Tao Ma · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.